Regional Tech Core Pilot Awards

GCDTR’s Regional Core on Technologies Advancing Translation and Equity provides funding for pilot grant proposals that identify persistent gaps in technology capabilities and barriers to the successful and equitable adoption and impacts of technologies in diabetes prevention and care. This opportunity is for investigators from the Core’s regional partner institutions to conduct exploratory, feasibility, and formative diabetes health equity studies to generate preliminary data to facilitate the submission of a subsequent funding application to NIDDK or other funding sources.  Budget:  up to $50,000 for one year.

Faculty researchers from the Jaeb Center for Health Research, University of Florida, University of Miami and University of Tennessee Health Sciences Center are eligible to apply as principal investigator for pilot and feasibility funding:

  • Early career faculty (e.g., Assistant Professor, Clinical Lecturer, Instructor) with limited current or past research support as PD/PI. Because the intent is that the project should lead to a subsequent NIH proposal, faculty should be eligible as a principal investigator for an NIH K or NIH R-level grant application at the time of submission.
  • Established investigators who (a) have no experience in diabetes translation research or (b) are proposing ideas that represent a clear departure from their past research and have a fully engaged junior-level Co-PI (post-doc or junior faculty). New investigators are a priority for funding. For any questions concerning eligibility, please contact Jeff Mills, Program Director, at  All projects should fall under the umbrella of T2 – T4 translation research and address diabetes, diabetes complications, prediabetes/metabolic syndrome, or obesity prevention or treatment.
  • T2 Research – translation to patients: Translation and/or implementation of interventions/approaches that have clearly demonstrated efficacy into real world health care settings, communities, and populations at risk with an emphasis on reach and sustainability.
  • T3 Research – translation to practice: Effectiveness, cost effectiveness, and comparative effectiveness studies conducted in practice sites, ensuring the translation of results from clinical studies into clinical practice settings.
  • T4 Research – translation to population: Dissemination and implementation research, which identifies and resolves barriers to implementation of evidence-based guidelines into community practice.

2024 Pilot and Feasibility Program Key Dates:

Workshop with Core Faculty:  Friday, February 16, 2024

Letter of Intent: Monday, April 1, 2024

Studio Consultations with Core Faculty: April – May, 2024

Application Receipt: Wednesday, May 1, 2024

Anticipated Start: Monday, July 1, 2024

RFP and Program Guidelines

Submit P&F Program Materials

NOTE:  If you are experiencing download issues with the Application Package on Chrome, right click on the link > copy link address > and paste in a new browser tab.

Request Studio Consultation

Studio Consultations provide investigators an opportunity to present their proposed research and obtain multidisciplinary guidance from clinical and translational science experts.  Studio Consultations provide a consultation with experts carefully selected from varied disciplines.  Request Studio Consultation >